Repositioning of Anti-parasitic Drugs in Cyclodextrin Inclusion Complexes for Treatment of Triple-Negative Breast Cancer

AAPS PharmSciTech
Josefina PriottiMauricio Menacho Márquez

Abstract

Drug repositioning refers to the identification of new therapeutic indications for drugs already approved. Albendazole and ricobendazole have been used as anti-parasitic drugs for many years; their therapeutic action is based on the inhibition of microtubule formation. Therefore, the study of their properties as antitumor compounds and the design of an appropriate formulation for cancer therapy is an interesting issue to investigate. The selected compounds are poorly soluble in water, and consequently, they have low and erratic bioavailability. In order to improve their biopharmaceutics properties, several formulations employing cyclodextrin inclusion complexes were developed. To carefully evaluate the in vitro and in vivo antitumor activity of these drugs and their complexes, several studies were performed on a breast cancer cell line (4T1) and BALB/c mice. In vitro studies showed that albendazole presented improved antitumor activity compared with ricobendazole. Furthermore, albendazole:citrate-β-cyclodextrin complex decreased significantly 4T1 cell growth both in in vitro and in vivo experiments. Thus, new formulations for anti-parasitic drugs could help to reposition them for new therapeutic indications, offering safer and ...Continue Reading

References

Jun 6, 2000·Advanced Drug Delivery Reviews·L Szente, J Szejtli
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Mar 29, 2005·Journal of Pharmaceutical Sciences·Zimei WuNatalie J Medlicott
Mar 31, 2009·Drug News & Perspectives·Edward L Tobinick
Jun 13, 2009·Science·Mark S BoguskiVikas P Sukhatme
Jul 10, 2012·International Journal of Pharmaceutics·Sergey V Kurkov, Thorsteinn Loftsson
May 4, 2013·The Lancet Oncology·Nicolas AndréEddy Pasquier
Jun 12, 2013·International Journal of Pharmaceutics·Chris Brough, R O Williams
Jun 27, 2013·Journal of Cheminformatics·Francesco NapolitanoDario Greco
Aug 10, 2013·Trends in Pharmacological Sciences·Subash C GuptaBharat B Aggarwal
Oct 15, 2013·International Journal of Biological Macromolecules·D LeonardiC J Salomon
Oct 19, 2013·Journal of Cancer Research and Clinical Oncology·Peter NygrenRolf Larsson
Feb 26, 2014·BMC Systems Biology·Chao WuAnil G Jegga
Apr 5, 2014·AAPS PharmSciTech·Yifei ZhangSong Li
Mar 7, 2015·Journal of Pharmaceutical and Biomedical Analysis·Paola Mura
Mar 21, 2015·International Journal of Biological Macromolecules·Ana V CodinaLucila I Hinrichsen
Apr 7, 2015·Carbohydrate Polymers·M João G FerreiraTeresa G Nunes
Apr 19, 2015·Journal of Nanobiotechnology·Lubna NooraniDavid L Morris
Jul 29, 2015·International Journal of Pharmaceutics·Yu ZhangXing Tang
Aug 10, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Djordje MedarevićSvetlana Ibrić
Dec 9, 2015·Bioorganic & Medicinal Chemistry Letters·Agustina GarcíaMaría C Lamas
Oct 7, 2016·Redox Biology·L S E P W CastroR C Pedrosa
Nov 20, 2016·International Journal of Pharmaceutics·Dominique Duchêne, Amélie Bochot
Dec 19, 2016·Carbohydrate Polymers·William T HayGordon W Selling
Apr 25, 2018·Drug Discovery Today·Jaime ConceiçãoJosé Manuel Sousa Lobo
May 31, 2018·AAPS PharmSciTech·Daniel RealClaudio J Salomon

❮ Previous
Next ❯

Citations

Feb 6, 2019·International Journal of Molecular Sciences·Simone Braga CarneiroÁdley Antonini Neves de Lima
Jul 11, 2019·Nature Reviews. Urology·Constantine AlifrangisMark Linch
Sep 9, 2020·Immune Network·Deok-Soo SonSamuel E Adunyah
Feb 26, 2019·BioMed Research International·Nagaraja SreeHarshaGirish Meravanige
May 8, 2020·Seminars in Cancer Biology·Anuradha KirtoniaManoj Garg
Nov 8, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roxana RacoviceanuCodruţa Şoica
Mar 9, 2021·Frontiers in Pharmacology·Luiza S E P Will CastroHeinz Jacobs
Jul 5, 2021·The Korean Journal of Parasitology·Jong-Yil ChaiSung-Jong Hong

❮ Previous
Next ❯

Methods Mentioned

BETA
Infrared Spectroscopy
X-ray
NMR

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.